{
    "nctId": "NCT03716245",
    "briefTitle": "Clinical Significance of Supraclavicular Lymph Node Dissection for Breast Cancer",
    "officialTitle": "A Multicenter, Randomised, Open-label Prospective Clinical Trial to Evaluate the Clinical Significance of Supraclavicular Lymph Node Dissection for Breast Cancer Patients With Ipsilateral Supraclavicular Lymph Node Metastasis",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer Stage III",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 180,
    "primaryOutcomeMeasure": "Disease free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Ability to understand the study procedures and contents, and willingness to voluntarily sign the written informed consent form;\n2. Age\u226475 years old, female;\n3. Histologically confirmed breast cancer;\n4. Histologically or cytologically confirmed ipsilateral supraclavicular lymph node metastasis\uff1b\n5. cT0-T3\uff1b\n6. low and moderate risk for anesthesia\n\nExclusion Criteria:\n\n1. Absolute and relative contraindication for surgery or radiation\uff1b\n2. existing distant metastasis before surgery\uff1b\n3. non-invasive breast cancer\uff1b\n4. with contralateral breast cancer\uff1b\n5. Previous history of breast cancer or other malignancies\uff1b\n6. ECOG\u22652\uff1b\n7. inflammatory breast cancer\uff1b\n8. pregnancy\uff1b\n9. any serious complications which caused patients not suitable to participate this study",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}